PAVM
PAVM
NASDAQ · Health Care

Pavmed Inc

$10.80
+0.22 (+2.08%)
As of Feb 8, 2:28 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 6.64M 6.38M 6.70M
Net Income 449.6K 418.8K 465.2K
EPS
Profit Margin 6.8% 6.6% 6.9%
Rev Growth +4.7% +12.0% -1.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 1.97M 2.13M 1.84M
Total Equity 5.67M 6.09M 6.42M
D/E Ratio 0.35 0.35 0.29
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 689.6K 672.1K 715.5K
Free Cash Flow 355.9K 349.1K 300.8K